KALA BIO, Inc.
KALA
$3.22
-$0.05-1.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.52% | 1.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.14% | -0.69% | |||
| Operating Income | 1.14% | 0.69% | |||
| Income Before Tax | 8.66% | 6.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.66% | 6.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.66% | 6.57% | |||
| EBIT | 1.14% | 0.69% | |||
| EBITDA | 1.21% | 0.71% | |||
| EPS Basic | 9.96% | 38.82% | |||
| Normalized Basic EPS | 5.54% | 41.86% | |||
| EPS Diluted | 9.96% | 38.82% | |||
| Normalized Diluted EPS | 5.54% | 41.86% | |||
| Average Basic Shares Outstanding | 1.45% | 52.72% | |||
| Average Diluted Shares Outstanding | 1.45% | 52.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||